Close Window

Digital Look Email A Friend

Scancell licenses Vaccitech IP for its next vaccine candidate

Published by Josh White on 7th November 2022

(Sharecast News) - Scancell has in-licensed 'SNAPvax' technology from clinical-stage biopharmaceutical company Vaccitech, it announced on Monday.

URL: http://www.digitallook.com/dl/news/story/33089336/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.